Bioalpha Holdings Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Bioalpha Holdings Berhad şirketinin toplam hissedar öz sermayesi MYR133.0M ve toplam borcu MYR4.7M olup, bu da borç-öz sermaye oranını 3.5% seviyesine getiriyor. Toplam varlıkları ve toplam yükümlülükleri sırasıyla MYR170.1M ve MYR37.1M dir.

Anahtar bilgiler

3.5%

Borç/özkaynak oranı

RM 4.66m

Borç

Faiz karşılama oranı	n/a
Nakit	RM 45.13m
Eşitlik	RM 132.96m
Toplam yükümlülükler	RM 37.14m
Toplam varlıklar	RM 170.10m

Son finansal sağlık güncellemeleri

Recent updates

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Mar 19

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Oct 04

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Jun 20

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Mar 01

Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Mar 29

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Mar 03

Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

Jan 20

How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

Nov 28

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BIOHLDG 'nin kısa vadeli varlıkları ( MYR63.9M ) kısa vadeli yükümlülüklerini ( MYR27.6M ) aşıyor.

Uzun Vadeli Yükümlülükler: BIOHLDG şirketinin kısa vadeli varlıkları ( MYR63.9M ) uzun vadeli yükümlülüklerini ( MYR9.6M ) aşmaktadır.

Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BIOHLDG şirketinin toplam borcundan daha fazla nakiti var.

Borcun Azaltılması: BIOHLDG şirketinin borç/öz sermaye oranı son 5 yılda 3.3% seviyesinden 3.5% seviyesine yükseldi.

Bilanço

Nakit Pist Analizi

Geçmişte ortalama olarak zarar eden şirketler için, en az 1 yıllık nakit akışına sahip olup olmadıklarını değerlendiriyoruz.

İstikrarlı Nakit Pisti: BIOHLDG şirketinin mevcut serbest nakit akışına göre 3 yıldan fazla bir süre için yeterli nakit pistine sahip olduğu belirtiliyor.

Tahmini Nakit Akışı: BIOHLDG serbest nakit akışı her yıl % { 10.5 1.5 |round(1)}} yıl boyunca yeterli nakit akışına sahip olacaktır.

Bioalpha Holdings Berhad Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 5/6

Anahtar bilgiler

Son finansal sağlık güncellemeleri

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Recent updates

Second quarter 2024 earnings released: RM0.005 loss per share (vs RM0.003 loss in 2Q 2023)

Bioalpha Holdings Berhad Announces Resignation of Goh Siow Cheng as Executive Director

First quarter 2024 earnings released: RM0.005 loss per share (vs RM0.014 loss in 1Q 2023)

Bioalpha Holdings Berhad Announces Resignation of Datuk Chong Loong Men as Executive Director

Bioalpha Holdings Berhad, Annual General Meeting, Jun 07, 2024

Full year 2023 earnings released: RM0.028 loss per share (vs RM0.038 loss in FY 2022)

New major risk - Share price stability

Third quarter 2023 earnings released: RM0.002 loss per share (vs RM0.005 loss in 3Q 2022)

New minor risk - Shareholder dilution

Bioalpha Holdings Berhad Appoints Tan Su Ning, Age 31, as Member of Risk Committee Directorate Independent and Non Executive, Date of Change 04 September 2023

Second quarter 2023 earnings released: RM0.003 loss per share (vs RM0.006 loss in 2Q 2022)

Less than half of directors are independent

Bioalpha Holdings Berhad Announces the Retirement of Encik Mohd Nasir Bin Abdullah as Independent and Non Executive Member of Remuneration Committee

First quarter 2023 earnings released: RM0.014 loss per share (vs RM0.003 loss in 1Q 2022)

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) A Risky Investment?

Full year 2022 earnings released: RM0.036 loss per share (vs RM0.001 loss in FY 2021)

Third quarter 2022 earnings released: RM0.005 loss per share (vs RM0.001 profit in 3Q 2021)

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Second quarter 2022 earnings released: RM0.006 loss per share (vs RM0.001 profit in 2Q 2021)

Bioalpha Holdings Berhad Announces Cessation of Office of Dato' Norhalim Bin Yunus as Non Independent and Non Executive Member of Remuneration Committee

Is Bioalpha Holdings Berhad (KLSE:BIOHLDG) Using Debt Sensibly?

Bioalpha Holdings Berhad Announces Cessation of Tan Sri Dato' Dr. Jalaludin Bin Syed Salim as Independent and Non Executive Chairman of Nomination Committee

First quarter 2022 earnings: EPS and revenues miss analyst expectations

JOE Holding (M) Investment Limited acquired a 12.40% stake in Bioalpha Holdings Berhad (KLSE : BIOHLDG) for MYR 45 million.

Bioalpha Holdings Berhad, Annual General Meeting, Jun 28, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Bioalpha Holdings Berhad (KLSE:BIOHLDG) Is Using Debt Safely

Third quarter 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Second quarter 2021 earnings released

First quarter 2021 earnings released: EPS RM0.001 (vs RM0.006 loss in 1Q 2020)

Why Bioalpha Holdings Berhad (KLSE:BIOHLDG) Could Be Worth Watching

Does Bioalpha Holdings Berhad (KLSE:BIOHLDG) Have A Healthy Balance Sheet?

Earnings beat expectations, revenue disappoints

Full year 2020 earnings released: RM0.037 loss per share (vs RM0.01 profit in FY 2019)

New 90-day low: RM0.25

Can You Imagine How Bioalpha Holdings Berhad's (KLSE:BIOHLDG) Shareholders Feel About The 42% Share Price Increase?

How Much Is Bioalpha Holdings Berhad's (KLSE:BIOHLDG) CEO Getting Paid?

New 90-day high: RM0.32

Bioalpha Holdings Berhad Provides Financial Guidance for the Year Ending December 31, 2020

First half earnings released

New 90-day high - RM0.31

Finansal Durum Analizi

Borç-Özkaynak Tarihçesi ve Analizi

Bilanço

Nakit Pist Analizi

Sağlıklı şirketleri keşfedin